1 / 28

Program Update November 8, 2012 Andrew J. Buckler, MS Principal Investigator, QI-Bench

Program Update November 8, 2012 Andrew J. Buckler, MS Principal Investigator, QI-Bench. With Funding Support provided by National Institute of Standards and Technology. Agenda. Update on large download capability (Patrick) First look at new user access concept (Andy)

stefan
Download Presentation

Program Update November 8, 2012 Andrew J. Buckler, MS Principal Investigator, QI-Bench

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Program Update November 8, 2012 Andrew J. Buckler, MS Principal Investigator, QI-Bench With Funding Support provided by National Institute of Standards and Technology

  2. Agenda • Update on large download capability (Patrick) • First look at new user access concept (Andy) • Consolidation of batch analysis, ISA file generation, and statistical analysis workflows (Gary and Jovanna) • Contour-based analysis (Team) 2

  3. Consolidation of BATCH ANALYSIS AND ISA file generation (Gary)

  4. Consolidation of statistical analysis workflows (Jovanna)

  5. 18 Objects that interact with the RDSM 18

  6. 19 19

  7. 20 Preprocess the data 20

  8. 21 Core Analysis: BiasAndLinearity 21

  9. 22 Core Analysis: ReaderPerformance 22

  10. 23 Composite Analysis: CrossSectionalVariability 23

  11. Contour-based Analysis • Purpose • Methods: • STAPLE • Meyer’s P-maps • MICCAI indices • DICE • File formats: • DICOM segmentation objects • AIM 4.0 • STL • MHT 24 24 24 24

  12. 25

  13. Value proposition of QI-Bench • Efficiently collect and exploit evidence establishing standards for optimized quantitative imaging: • Users want confidence in the read-outs • Pharma wants to use them as endpoints • Device/SW companies want to market products that produce them without huge costs • Public wants to trust the decisions that they contribute to • By providing a verification framework to develop precompetitive specifications and support test harnesses to curate and utilize reference data • Doing so as an accessible and open resource facilitates collaboration among diverse stakeholders 26

  14. Summary:QI-Bench Contributions • We make it practical to increase the magnitude of data for increased statistical significance. • We provide practical means to grapple with massive data sets. • We address the problem of efficient use of resources to assess limits of generalizability. • We make formal specification accessible to diverse groups of experts that are not skilled or interested in knowledge engineering. • We map both medical as well as technical domain expertise into representations well suited to emerging capabilities of the semantic web. • We enable a mechanism to assess compliance with standards or requirements within specific contexts for use. • We take a “toolbox” approach to statistical analysis. • We provide the capability in a manner which is accessible to varying levels of collaborative models, from individual companies or institutions to larger consortia or public-private partnerships to fully open public access. 27

  15. QI-BenchStructure / Acknowledgements • Prime: BBMSC (Andrew Buckler, Gary Wernsing, Mike Sperling, Matt Ouellette, Kjell Johnson, Jovanna Danagoulian) • Co-Investigators • Kitware (Rick Avila, Patrick Reynolds, JulienJomier, Mike Grauer) • Stanford (David Paik) • Financial support as well as technical content: NIST (Mary Brady, Alden Dima, John Lu) • Collaborators / Colleagues / Idea Contributors • Georgetown (Baris Suzek) • FDA (Nick Petrick, Marios Gavrielides) • UMD (Eliot Siegel, Joe Chen, Ganesh Saiprasad, Yelena Yesha) • Northwestern (Pat Mongkolwat) • UCLA (Grace Kim) • VUmc (Otto Hoekstra) • Industry • Pharma: Novartis (Stefan Baumann), Merck (Richard Baumgartner) • Device/Software: Definiens, Median, Intio, GE, Siemens, Mevis, Claron Technologies, … • Coordinating Programs • RSNA QIBA (e.g., Dan Sullivan, Binsheng Zhao) • Under consideration: CTMM TraIT (Andre Dekker, JeroenBelien) 28

More Related